Literature DB >> 13221275

[Incorporation of physiologically-active substances into a colloidal blood plasma substitute. I. Incorporation of mescaline peptide into polyvinylpyrrolidone].

H JATZKEWITZ.   

Abstract

Entities:  

Keywords:  PHENYLETHYLAMINES; POLYVINYLPYRROLIDONE/therapeutic use

Mesh：

Substances：

Year:  1954        PMID： 13221275

Source DB:  PubMed          Journal:  Hoppe Seylers Z Physiol Chem        ISSN： 0018-4888


× No keyword cloud information.
  4 in total

Review 1.  Strategies in the design of nanoparticles for therapeutic applications.

Authors:  Robby A Petros; Joseph M DeSimone
Journal:  Nat Rev Drug Discov       Date:  2010-07-09       Impact factor: 84.694

Review 2.  Therapeutic prospects of microRNAs in cancer treatment through nanotechnology.

Authors:  Rajendra Awasthi; Michael John Rathbone; Philip Michael Hansbro; Mary Bebawy; Kamal Dua
Journal:  Drug Deliv Transl Res       Date:  2018-02       Impact factor: 4.617

Review 3.  Nanotechnology in cancer therapy.

Authors:  Burcu Aslan; Bulent Ozpolat; Anil K Sood; Gabriel Lopez-Berestein
Journal:  J Drug Target       Date:  2013-09-30       Impact factor: 5.121

4.  PEG: Will It Come Back to You? Polyethelyne Glycol Immunogenicity, COVID Vaccines, and the Case for New PEG Derivatives and Alternatives.

Authors:  Yi Wen Kong; Erik C Dreaden
Journal:  Front Bioeng Biotechnol       Date:  2022-04-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.